| Application no. and date | 17764092.7 (espacenet) (Federated) (European Patent Register), 20170309 | | Patent/reg. no. and date | DK/EP 3426251, 20220420 | | Publication date | 20190116 | | Priority no. and date | US 201662306487 P, 20160310 | | EP pub. no. and date |
EP 3426251 20190116 | | Effective date | | | Applicant/owner | Janssen Pharmaceutica NV, Turnhoutseweg 30
2340 Beerse, BE | | Applicant ref. no. | P79471DK01 | | Inventor | DE BOER, Peter, Turnhoutseweg 30
B-2340 Beerse, BE,
KENT, Justine, M., 1125 Trenton-harbourton Road
Titusville,NJ 08560, US,
DREVETS, Wayne, C., 1125 Trenton-harbourton Road
Titusville,NJ 08560, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 45/06 (2006.01) , A61K 47/38 (2006.01) , A61K 9/00 (2006.01) , A61K 9/10 (2006.01) , A61K 9/20 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF DEPRESSION UNDER ANVENDELSE AF OREXIN-2-RECEPTORANTAGONISTER | | Int. application no. | US2017021565 | | Int. publication no. | WO2017156266 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
